Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

Completed Phase 2 randomized, double-blind, placebo-controlled trial evaluating CVT-E002 for seasonal allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• CVT-E002

Snippet

Sponsor: Afexa Life Sciences Inc | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED